USFDA approves Astellas' Veozah’ for treatment of vasomotor symptoms due to menopause
VEOZAH is first-in-class treatment option to reduce the frequency and severity of moderate to severe VMS due to menopause
VEOZAH is first-in-class treatment option to reduce the frequency and severity of moderate to severe VMS due to menopause
Milan is also an important hub for the distribution of pharmaceuticals to the rest of Europe
Krsnaa Diagnostics has commenced its fourth out of eight Diagnostics Center in Ayodhya
China recorded unprecedented improvement in its API manufacturing score in the 2022 end of year CPHI Survey
Cooperative agreement with U.S. Government to advance U.S. biopharma industry and ensure pandemic preparedness
Cipla has recently signed an agreement to make and market the diabetes therapy Galvus and its combination brands in India from 01 January 2026.
New high-tech facility in Biberach offers attractive workplaces for more than 500 scientists
This is the first time the Agency has authorized the Phase 3 clinical evaluation in the U.S of a microbiota-based live biotherapeutic based on a pooling technology
Bayer reported the highest market capitalization growth of 23.1% during Q1 2023
The company will set up a MRI, CT Scan, Sonography- Ultrasound, X-Ray Center and Pathology Lab
Subscribe To Our Newsletter & Stay Updated